Servier - Latest News and Investment Deals
  • All Technology
  • AI
  • Autonomy
  • B2B Growth
  • Big Data
  • BioTech
  • ClimateTech
  • Consumer Tech
  • Crypto
  • Cybersecurity
  • DevOps
  • Digital Marketing
  • Ecommerce
  • EdTech
  • Enterprise
  • FinTech
  • GovTech
  • Hardware
  • HealthTech
  • HRTech
  • LegalTech
  • Nanotech
  • PropTech
  • Quantum
  • Robotics
  • SaaS
  • SpaceTech
AllNewsDealsSocialBlogsVideosPodcastsDigests

Technology Pulse

EMAIL DIGESTS

Daily

Every morning

Weekly

Sunday recap

NewsDealsSocialBlogsVideosPodcasts
HomeServier
Servier logo

Servier

0 followers

About Servier

Servier is a global pharmaceutical company focused on oncology and neurology, with research spanning cardiovascular diseases, cancers, diabetes, immune-inflammatory and neuropsychiatric diseases. The US arm communicates a commitment to science-driven therapeutics and patient care, supported by in-house research capabilities and a broad pipeline. It emphasizes partnerships, clinical development, and a patient-centric approach across its programs. Servier US highlights its leadership in oncology and neurology while addressing rare diseases and unmet medical needs.

Recent News

Recent Deals

Key Team Members

Olivier Laureau

President and CEO of the Servier Group and the Servier International Foundation for Research

Damien Catoir

Executive Vice President, General Counsel and Corporate Secretary

Virginie Dominguez

Executive Vice President, Digital, Data and Information Systems

Hani Friedman Bouganim

Executive Vice President, Manufacturing, Quality and Supply Chain

Dr Arnaud Lallouette

Executive Vice President, Global Medical & Patient Affairs

Key Facts

HQ Location

Boston, United States

Founded

2018

Employees

501-1K

Status

Investor

Investor Type

Corporate Investor

Website

https://servier.us